Journal of Clinical Oncology, Vol 11, 336-344, Copyright © 1993 by American Society of Clinical Oncology

ARTICLES

Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group

N Murray, P Coy, JL Pater, I Hodson, A Arnold, BC Zee, D Payne, EC Kostashuk, WK Evans and P Dixon
British Columbia Cancer Agency Vancouver Clinic, Canada.

PURPOSE: The importance of the timing of thoracic irradiation (TI) in the combined modality therapy of limited-stage small-cell lung cancer (SCLC) was assessed in a randomized trial. METHODS: All 308 eligible patients received cyclophosphamide, doxorubicin, and vincristine (CAV) alternating with etoposide and cisplatin (EP) every 3 weeks for three cycles of each chemotherapy regimen. Patients randomized to early TI received 40 Gy in 15 fractions over 3 weeks to the primary site concurrent with the first cycle of EP (week 3), and late TI patients received the same radiation concurrent with the last cycle of EP (week 15). After completion of all chemotherapy and TI, patients without progressive disease received prophylactic cranial irradiation (25 Gy in 10 fractions over 2 weeks). RESULTS: Although complete remission rates were not significantly different between the two arms, progression-free survival (P = .036) and overall survival (P = .008) were superior in the early TI arm. Patients in the late TI arm had a higher risk of brain metastases (P = .006). CONCLUSION: The early administration of TI in the combined modality therapy of limited-stage SCLC is superior to late or consolidative TI.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. J. Beitler and J. S. Cooper Seduction by Induction? J. Clin. Oncol., January 1, 2009; 27(1): 9 - 10. [Full Text] [PDF]

				S A Kenfield, E K Wei, M J Stampfer, B A Rosner, and G A Colditz Comparison of aspects of smoking among the four histological types of lung cancer Tob. Control, June 1, 2008; 17(3): 198 - 204. [Abstract] [Full Text] [PDF]

				M. A. Socinski and J. A. Bogart Limited-Stage Small-Cell Lung Cancer: The Current Status of Combined-Modality Therapy J. Clin. Oncol., September 10, 2007; 25(26): 4137 - 4145. [Abstract] [Full Text] [PDF]

				D. J. Samson, J. Seidenfeld, G. R. Simon, A. T. Turrisi III, C. Bonnell, K. M. Ziegler, and N. Aronson Evidence for Management of Small Cell Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 314S - 323S. [Abstract] [Full Text] [PDF]

				G. R. Simon and A. Turrisi Management of Small Cell Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 324S - 339S. [Abstract] [Full Text] [PDF]

				S. Laurie, K Ding, M Whitehead, R Feld, N Murray, F. Shepherd, and L Seymour The impact of anemia on outcome of chemoradiation for limited small-cell lung cancer: a combined analysis of studies of the National Cancer Institute of Canada Clinical Trials Group Ann. Onc., June 1, 2007; 18(6): 1051 - 1055. [Abstract] [Full Text] [PDF]

				D De Ruysscher, C Dehing, R-H Bremer, S. Bentzen, F Koppe, M Pijls-Johannesma, L Harzee, A Minken, R Wanders, M Hochstenbag, et al. Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients Ann. Onc., May 1, 2007; 18(5): 909 - 916. [Abstract] [Full Text] [PDF]

				M. C. Perry Thoracic Radiation Therapy in Limited Stage Small-Cell Lung Cancer: Timing Is Everything...Isn't It? J. Clin. Oncol., August 20, 2006; 24(24): 3815 - 3816. [Full Text] [PDF]

				S. G. Spiro, L. E. James, R. M. Rudd, C. W. Trask, J. S. Tobias, M. Snee, D. Gilligan, P. A. Murray, M. C. R. de Elvira, K. M. O'Donnell, et al. Early Compared With Late Radiotherapy in Combined Modality Treatment for Limited Disease Small-Cell Lung Cancer: A London Lung Cancer Group Multicenter Randomized Clinical Trial and Meta-Analysis J. Clin. Oncol., August 20, 2006; 24(24): 3823 - 3830. [Abstract] [Full Text] [PDF]

				J. A. Bogart, S. L. Seagren, and A. Glicksman Radiation oncology research in the cancer and leukemia group B. Clin. Cancer Res., June 1, 2006; 12(11): 3628s - 3634s. [Abstract] [Full Text] [PDF]

				D. De Ruysscher, M. Pijls-Johannesma, J. Vansteenkiste, A. Kester, I. Rutten, and P. Lambin Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer Ann. Onc., April 1, 2006; 17(4): 543 - 552. [Abstract] [Full Text] [PDF]

				A. M. Brade and I. F. Tannock Scheduling of Radiation and Chemotherapy for Limited-Stage Small-Cell Lung Cancer: Repopulation As a Cause of Treatment Failure? J. Clin. Oncol., March 1, 2006; 24(7): 1020 - 1022. [Full Text] [PDF]

				D. De Ruysscher, M. Pijls-Johannesma, S. M. Bentzen, A. Minken, R. Wanders, L. Lutgens, M. Hochstenbag, L. Boersma, B. Wouters, G. Lammering, et al. Time Between the First Day of Chemotherapy and the Last Day of Chest Radiation Is the Most Important Predictor of Survival in Limited-Disease Small-Cell Lung Cancer J. Clin. Oncol., March 1, 2006; 24(7): 1057 - 1063. [Abstract] [Full Text] [PDF]

				N. Thatcher, W. Qian, P. I. Clark, P. Hopwood, R. J. Sambrook, R. Owens, R. J. Stephens, and D. J. Girling Ifosfamide, Carboplatin, and Etoposide With Midcycle Vincristine Versus Standard Chemotherapy in Patients With Small-Cell Lung Cancer and Good Performance Status: Clinical and Quality-of-Life Results of the British Medical Research Council Multicenter Randomized LU21 Trial J. Clin. Oncol., November 20, 2005; 23(33): 8371 - 8379. [Abstract] [Full Text] [PDF]

				B. Movsas Will Future Progress in Non-Small-Cell Lung Cancer Be Step by Step ... or by Leaps and Bounds? J. Clin. Oncol., September 1, 2005; 23(25): 5859 - 5861. [Full Text] [PDF]

				S. G. Spiro and G. A. Silvestri One Hundred Years of Lung Cancer Am. J. Respir. Crit. Care Med., September 1, 2005; 172(5): 523 - 529. [Abstract] [Full Text] [PDF]

				K. Kubota, Y. Nishiwaki, T. Sugiura, K. Noda, K. Mori, M. Kawahara, S. Negoro, K. Watanabe, F. Imamura, T. Tamura, et al. Pilot Study of Concurrent Etoposide and Cisplatin Plus Accelerated Hyperfractionated Thoracic Radiotherapy Followed by Irinotecan and Cisplatin for Limited-Stage Small Cell Lung Cancer: Japan Clinical Oncology Group 9903 Clin. Cancer Res., August 1, 2005; 11(15): 5534 - 5538. [Abstract] [Full Text] [PDF]

				S. Singh, W. Parulekar, N. Murray, R. Feld, W. K. Evans, D. Tu, and F. A. Shepherd Influence of Sex on Toxicity and Treatment Outcome in Small-Cell Lung Cancer J. Clin. Oncol., February 1, 2005; 23(4): 850 - 856. [Abstract] [Full Text] [PDF]

				J. Ragaz, I. A. Olivotto, J. J. Spinelli, N. Phillips, S. M. Jackson, Kenneth. S. Wilson, M. A. Knowling, C. M. L. Coppin, L. Weir, K. Gelmon, et al. Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized Trial J Natl Cancer Inst, January 19, 2005; 97(2): 116 - 126. [Abstract] [Full Text] [PDF]

				D. B. Fried, D. E. Morris, C. Poole, J. G. Rosenman, J. S. Halle, F. C. Detterbeck, T. A. Hensing, and M. A. Socinski Systematic Review Evaluating the Timing of Thoracic Radiation Therapy in Combined Modality Therapy for Limited-Stage Small-Cell Lung Cancer J. Clin. Oncol., December 1, 2004; 22(23): 4837 - 4845. [Abstract] [Full Text] [PDF]

				M. Huncharek and R. McGarry A Meta-Analysis of the Timing of Chest Irradiation in the Combined Modality Treatment of Limited-Stage Small Cell Lung Cancer Oncologist, November 1, 2004; 9(6): 665 - 672. [Abstract] [Full Text] [PDF]

				Q.-T. Le, J. McCoy, S. Williamson, J. Ryu, L. E. Gaspar, M. J. Edelman, S. R. Dakhil, S. D. Sides, J. J. Crowley, and D. R. Gandara Phase I Study of Tirapazamine Plus Cisplatin/Etoposide and Concurrent Thoracic Radiotherapy in Limited-Stage Small Cell Lung Cancer (S0004): A Southwest Oncology Group Study Clin. Cancer Res., August 15, 2004; 10(16): 5418 - 5424. [Abstract] [Full Text] [PDF]

				A. Spira and D. S. Ettinger Multidisciplinary Management of Lung Cancer N. Engl. J. Med., January 22, 2004; 350(4): 379 - 392. [Full Text] [PDF]

				M. J. Edelman, K. Chansky, L. E. Gaspar, B. Leigh, G. R. Weiss, S. A. Taylor, J. Crowley, R. Livingston, and D. R. Gandara Phase II Trial of Cisplatin/Etoposide and Concurrent Radiotherapy Followed by Paclitaxel/Carboplatin Consolidation for Limited Small-Cell Lung Cancer: Southwest Oncology Group 9713 J. Clin. Oncol., January 1, 2004; 22(1): 127 - 132. [Abstract] [Full Text] [PDF]

				S.-H. Lee, Y. C. Ahn, H. J. Kim, D. H. Lim, S. I. Lee, E. Nam, S. H. Park, J. Park, K.-E. Lee, J. O. Park, et al. Early Concurrent Chemoradiotherapy with Prolonged Oral Etoposide and Cisplatin for Limited-stage Small-cell Lung Cancer Jpn. J. Clin. Oncol., December 1, 2003; 33(12): 620 - 625. [Abstract] [Full Text] [PDF]

				P.J. Hoskins, K.D. Swenerton, J.A. Pike, P. Lim, C. Aquino-Parsons, F. Wong, and N. Lee Small-Cell Carcinoma of the Cervix: Fourteen Years of Experience at a Single Institution Using a Combined-Modality Regimen of Involved-Field Irradiation and Platinum-Based Combination Chemotherapy J. Clin. Oncol., September 15, 2003; 21(18): 3495 - 3501. [Abstract] [Full Text] [PDF]

				R Booton, M Jones, and N Thatcher Lung cancer * 7: Management of lung cancer in elderly patients Thorax, August 1, 2003; 58(8): 711 - 720. [Full Text] [PDF]

				A Price Lung cancer * 5: State of the art radiotherapy for lung cancer Thorax, May 1, 2003; 58(5): 447 - 452. [Abstract] [Full Text] [PDF]

				G. M.M. Videtic, L. W. Stitt, A. R. Dar, W. I. Kocha, A. T. Tomiak, P. T. Truong, M. D. Vincent, and E. W. Yu Continued Cigarette Smoking by Patients Receiving Concurrent Chemoradiotherapy for Limited-Stage Small-Cell Lung Cancer Is Associated With Decreased Survival J. Clin. Oncol., April 15, 2003; 21(8): 1544 - 1549. [Abstract] [Full Text] [PDF]

				J. Huang, L. Barbera, M. Brouwers, G. Browman, and W. J. Mackillop Does Delay in Starting Treatment Affect the Outcomes of Radiotherapy? A Systematic Review J. Clin. Oncol., February 1, 2003; 21(3): 555 - 563. [Abstract] [Full Text] [PDF]

				G. R. Simon and H. Wagner Small Cell Lung Cancer Chest, January 1, 2003; 123 (2009): 259S - 271S. [Abstract] [Full Text] [PDF]

				S. G. Spiro and J. C. Porter Lung Cancer--Where Are We Today?: Current Advances in Staging and Nonsurgical Treatment Am. J. Respir. Crit. Care Med., November 1, 2002; 166(9): 1166 - 1196. [Abstract] [Full Text] [PDF]

				M. Machtay The Early Rad Catches the Tumor? J. Clin. Oncol., July 15, 2002; 20(14): 3045 - 3047. [Full Text] [PDF]

				M. Takada, M. Fukuoka, M. Kawahara, T. Sugiura, A. Yokoyama, S. Yokota, Y. Nishiwaki, K. Watanabe, K. Noda, T. Tamura, et al. Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Cisplatin and Etoposide for Limited-Stage Small-Cell Lung Cancer: Results of the Japan Clinical Oncology Group Study 9104 J. Clin. Oncol., July 15, 2002; 20(14): 3054 - 3060. [Abstract] [Full Text] [PDF]

				J.-H. Lee, J.-H. Lee, J.-H. Ahn, H. Bahng, T.-W. Kim, Y.-K. Kang, K.-H. Lee, J.-C. Kim, C.-S. Yu, J.-H. Kim, et al. Randomized Trial of Postoperative Adjuvant Therapy in Stage II and III Rectal Cancer to Define the Optimal Sequence of Chemotherapy and Radiotherapy: A Preliminary Report J. Clin. Oncol., April 1, 2002; 20(7): 1751 - 1758. [Abstract] [Full Text] [PDF]

				K. Osterlind Chemotherapy in small cell lung cancer Eur. Respir. J., December 1, 2001; 18(6): 1026 - 1043. [Abstract] [Full Text] [PDF]

				R. Komaki, M. H. Chasen, W. D. Travis, J. B. Putnam, F. V. Fossella, R. W. Byhardt, and J. Y. Ro Oncodiagnosis Panel: 1999: Cancer of the Lung: Oncodiagnosis RadioGraphics, November 1, 2001; 21(6): 1573 - 1596. [Full Text] [PDF]

				T. J. Robnett, M. Machtay, J. P. Stevenson, K. M. Algazy, and S. M. Hahn Factors Affecting the Risk of Brain Metastases After Definitive Chemoradiation for Locally Advanced Non-Small-Cell Lung Carcinoma J. Clin. Oncol., March 1, 2001; 19(5): 1344 - 1349. [Abstract] [Full Text] [PDF]

				I. S. Woo, Y. S. Park, S. H. Kwon, Y. I. Park, J. A. Lee, M. J. Park, I. G. Hyun, K. S. Jung, H. S. Bae, D. H. Oh, et al. A Phase II Study of VP-16-Ifosfamide-Cisplatin Combination Chemotherapy Plus Early Concurrent Thoracic Irradiation for Previously Untreated Limited Small Cell Lung Cancer Jpn. J. Clin. Oncol., December 1, 2000; 30(12): 542 - 546. [Abstract] [Full Text] [PDF]

				M. H. Cohen Thalidomide in the treatment of high-grade gliomas. J. Clin. Oncol., October 1, 2000; 18(19): 3453 - 3453. [Full Text] [PDF]

				B. Glisson, C. Scott, R. Komaki, B. Movsas, and H. Wagner Cisplatin, Ifosfamide, Oral Etoposide, and Concurrent Accelerated Hyperfractionated Thoracic Radiation for Patients With Limited Small-Cell Lung Carcinoma: Results of Radiation Therapy Oncology Group Trial 93-12 J. Clin. Oncol., August 16, 2000; 18(16): 2990 - 2995. [Abstract] [Full Text] [PDF]

				A. Hugli, D. Moro, B. Mermillod, M. Bolla, P. Alberto, H. Bonnefoi, and R. Miralbell Phase II Trial of Up-Front Accelerated Thoracic Radiotherapy Combined With Chemotherapy and Optional Up-Front Prophylactic Cranial Irradiation in Limited Small-Cell Lung Cancer J. Clin. Oncol., April 1, 2000; 18(8): 1662 - 1667. [Abstract] [Full Text] [PDF]

				N. Levitan, A. Dowlati, D. Shina, M. Craffey, W. Mackay, R. DeVore, J. Jett, S. C. Remick, A. Chang, and D. Johnson Multi-Institutional Phase I/II Trial of Paclitaxel, Cisplatin, and Etoposide With Concurrent Radiation for Limited-Stage Small-Cell Lung Carcinoma J. Clin. Oncol., March 1, 2000; 18(5): 1102 - 1102. [Abstract] [Full Text] [PDF]

				D. H. Johnson Management of Small Cell Lung Cancer* : Current State of the Art Chest, December 1, 1999; 116 (2009): 525S - 530S. [Abstract] [Full Text] [PDF]

				L. B. Marks and G. Sibley The Rationale and Use of Three-Dimensional Radiation Treatment Planning for Lung Cancer* Chest, December 1, 1999; 116 (2009): 539S - 545S. [Abstract] [Full Text] [PDF]

				J. A. Bonner, J. A. Sloan, T. G. Shanahan, B. J. Brooks, R. S. Marks, J. E. Krook, J. B. Gerstner, A. Maksymiuk, R. Levitt, J. A. Mailliard, et al. Phase III Comparison of Twice-Daily Split-Course Irradiation Versus Once-Daily Irradiation for Patients With Limited Stage Small-Cell Lung Carcinoma J. Clin. Oncol., September 1, 1999; 17(9): 2681 - 2681. [Abstract] [Full Text] [PDF]

				K. Furuse, M. Fukuoka, M. Kawahara, H. Nishikawa, Y. Takada, S. Kudoh, N. Katagami, and Y. Ariyoshi Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non-Small-Cell Lung Cancer J. Clin. Oncol., September 1, 1999; 17(9): 2692 - 2692. [Abstract] [Full Text] [PDF]

				A. Auperin, R. Arriagada, J.-P. Pignon, C. Le Pechoux, A. Gregor, R. J. Stephens, P. E.G. Kristjansen, B. E. Johnson, H. Ueoka, H. Wagner, et al. Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission N. Engl. J. Med., August 12, 1999; 341(7): 476 - 484. [Abstract] [Full Text] [PDF]

				B. Jeremic, Y. Shibamoto, N. Nikolic, B. Milicic, S. Milisavljevic, A. Dagovic, J. Aleksandrovic, and G. Radosavljevic-Asic Role of Radiation Therapy in the Combined-Modality Treatment of Patients With Extensive Disease Small-Cell Lung Cancer: A Randomized Study J. Clin. Oncol., July 1, 1999; 17(7): 2092 - 2092. [Abstract] [Full Text] [PDF]

				A. T. Turrisi, K. Kim, R. Blum, W. T. Sause, R. B. Livingston, R. Komaki, H. Wagner, S. Aisner, and D. H. Johnson Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide N. Engl. J. Med., January 28, 1999; 340(4): 265 - 271. [Abstract] [Full Text] [PDF]